Variables | n | MUC1 (+) | n | MUC3 (+) |
---|---|---|---|---|
NS, not significant. | ||||
Sex | ||||
Male | 34 | 23 (67.6%) | 34 | 23 (67.6%) |
Female | 12 | 6 (50.0%) | 11 | 7 (63.6%) |
p Value | NS | NS | ||
Tumour location | ||||
Fundus | 7 | 6 (85.7%) | 7 | 3 (42.9%) |
Body | 13 | 6 (46.2%) | 13 | 9 (69.2%) |
Antrum | 26 | 17 (65.4%) | 25 | 18 (72.0%) |
p Value | NS | NS | ||
Size | ||||
≤5 cm | 31 | 24 (77.4%) | 31 | 21 (67.7%) |
>5 cm | 15 | 5 (33.3%) | 14 | 9 (64.3%) |
p Value | <0.01 | NS | ||
Differentiation | ||||
Well/moderate | 26 | 17 (65.4%) | 26 | 20 (76.9%) |
Poor | 17 | 10 (58.8%) | 16 | 8 (50.0%) |
Mucoid | 3 | 2 (66.7%) | 3 | 2 (66.7%) |
p Value | NS | NS | ||
Metastasis | ||||
Present | 23 | 11 (47.8%) | 23 | 20 (87.0%) |
Absent | 23 | 18 (78.3%) | 22 | 10 (45.5%) |
p Value | <0.05 | <0.01 | ||
Serosal invasion | ||||
Present | 26 | 16 (61.5%) | 25 | 20 (80.0%) |
Absent | 20 | 13 (65.0%) | 20 | 10 (50.0%) |
p Value | NS | <0.05 | ||
Clinical stage | ||||
I–II | 26 | 21 (80.8%) | 25 | 12 (48.0%) |
III–IV | 20 | 8 (40.0%) | 20 | 18 (90.0%) |
p Value | <0.01 | <0.05 | ||
Types of carcinoma | ||||
Intestinal | 21 | 13 (61.9%) | 20 | 12 (60.0%) |
Diffuse | 17 | 11 (64.7%) | 17 | 11 (64.7%) |
Mixed | 8 | 5 (62.5%) | 8 | 7 (87.5%) |
p Value | NS | NS |